iBio
IBIO
#10296
Rank
โ‚ฌ46.79 M
Marketcap
0,66ย โ‚ฌ
Share price
-4.00%
Change (1 day)
-29.80%
Change (1 year)

Earnings for iBio (IBIO)

Earnings in 2026 (TTM): -โ‚ฌ28.46 Million

According to iBio's latest financial reports the company's current earnings are โ‚ฌ0.1 Million. In 2025 the company made an earning of -โ‚ฌ22.3 Million a decrease over its 2024 earnings that were of -โ‚ฌ12.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for iBio from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ28.46 Million27.62%
2025 -โ‚ฌ22.3 Million75.34%
2024 -โ‚ฌ12.72 Million-32.2%
2023 -โ‚ฌ18.76 Million-50.39%
2022 -โ‚ฌ37.81 Million122.23%
2021 -โ‚ฌ17.01 Million-12.52%
2020 -โ‚ฌ19.45 Million45%
2019 -โ‚ฌ13.41 Million-3.71%
2018 -โ‚ฌ13.93 Million5.52%
2017 -โ‚ฌ13.2 Million18.82%
2016 -โ‚ฌ11.11 Million60.34%
2015 -โ‚ฌ6.93 Million38.31%
2014 -โ‚ฌ5.01 Million25.01%
2013 -โ‚ฌ4.01 Million
2010 -โ‚ฌ11.11 Million360.89%
2009 -โ‚ฌ2.41 Million5.77%
2008 -โ‚ฌ2.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ16.99 B-56,845.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-โ‚ฌ33.76 Million 12.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚ฌ0.14 Billion 364.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-โ‚ฌ0.18 Billion 489.86%๐Ÿ‡บ๐Ÿ‡ธ USA